FTC Releases Interim Staff Report on Prescription Drug Middlemen

Report details how prescription drug middleman profit at the expense of patients by inflating drug costs and squeezing Main Street pharmacies

Previous
Previous

Drug middlemen in the hot seat: Q&A with USC Schaeffer Center’s Erin Trish

Next
Next

What to Do if You’re Overpaying for Prescriptions